A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Clinical trial NCT04025216 · TERMINATED

Trial details

NCT number: NCT04025216
Sponsor: Kite, A Gilead Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Ovarian Cancer Fallopian Tube Cancer Triple Negative Breast Cancer Multiple Myeloma Pancreatic Ductal Adenocarcinoma

Start date: 2019-10-10
Primary completion: 2022-12-02
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.